Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies
European Journal of Pharmaceutical Sciences · 2024-12 · 203 · 106928
DOI: 10.1016/j.ejps.2024.106928 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024-12. Verfasst von Christina Glader und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: christina.glader@rcpe.at. Hauptthemen laut MEDLINE: Nanoparticles, Particle Size, Lipids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FFG, BMDW, BMK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: christina.glader@rcpe.at.
- University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, Graz 8010, Austria. Electronic address: ramona.jeitler@uni-graz.at.
- InProcess-LSP, Kloosterstraat 9, Oss 5349 AB, The Netherlands. Electronic address: y.wang@inprocess-lsp.com.
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: carolin.tetyczka@rcpe.at.
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: manuel.zettl@rcpe.at.
- Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, Graz 8010, Austria. Electronic address: matthias.schloemer@rcpe.at.
Förderung
- FFG
- BMDW
- BMK
- SFG
- Karl-Franzens-Universität Graz
- Land Steiermark
Zitieren
APA
Glader, C., Jeitler, R., Wang, Y., Tetyczka, C., Zettl, M., Schlömer, M., Caisse, P., Mesite, S., Stephan, S., Bourgeaux, V., & Roblegg, E. (2024). Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies. European Journal of Pharmaceutical Sciences, 203, 106928. https://doi.org/10.1016/j.ejps.2024.106928
Vancouver
Glader C, Jeitler R, Wang Y, Tetyczka C, Zettl M, Schlömer M, et al. Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies. European Journal of Pharmaceutical Sciences. 2024;203:106928. doi:10.1016/j.ejps.2024.106928
BibTeX
@article{Glader2024,
author = {Glader, Christina and Jeitler, Ramona and Wang, Yan and Tetyczka, Carolin and Zettl, Manuel and Schlömer, Matthias and Caisse, Philippe and Mesite, Steve and Stephan, Svea and Bourgeaux, Vanessa and Roblegg, Eva},
title = {Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
volume = {203},
pages = {106928},
doi = {10.1016/j.ejps.2024.106928}
}
EUVIMED